首页> 美国卫生研究院文献>Current Controlled Trials in Cardiovascular Medicine >Sahaj Samadhi meditation vs a Health Enhancement Program in improving late-life depression severity and executive function: study protocol for a two-site randomized controlled trial
【2h】

Sahaj Samadhi meditation vs a Health Enhancement Program in improving late-life depression severity and executive function: study protocol for a two-site randomized controlled trial

机译:Sahaj Samadhi冥想与健康改善计划在改善晚期抑郁症的严重程度和执行功能方面的研究:一项针对两点随机对照试验的研究方案

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundRecent estimates suggest an 11% prevalence of current late-life depression (LLD) and a lifetime prevalence of 16–20%. LLD leads to cognitive disturbance as well as a nearly two to three times increased risk of dementia. We conducted a recent randomized controlled trial (RCT) which demonstrated that Sahaj Samadhi meditation (SSM), an easy-to-implement, meditation-based augmentation strategy, led to higher rates of symptom remission when compared to treatment as usual (40.0 vs 16.3%; odds ratio, 3.36; 95% CI 1.06–10.64; p = 0.040). Here we present a protocol describing a two-site, blinded, RCT, comparing an SSM arm to an active-control arm – a Health Enhancement Program (HEP) intervention – in their ability to reduce depressive symptoms and improve executive functioning, among several other exploratory outcomes.
机译:背景最近的估计表明当前的晚期抑郁症(LLD)患病率为11%,一生的患病率为16-20%。 LLD会导致认知障碍,并增加痴呆症风险近两到三倍。我们进行了一项近期的随机对照试验(RCT),该试验证明,以简单的,基于冥想的增强策略Sahaj Samadhi冥想(SSM)与通常的治疗方法相比,可带来更高的症状缓解率(40.0 vs 16.3) %;比值比为3.36; 95%CI为1.06–10.64; p = 0.040)。在这里,我们介绍一种协议,该协议描述了一个两点,双盲的RCT,将SSM臂与主动控制臂(健康增强计划(HEP)干预)进行了比较,以减轻抑郁症状和改善执行功能,探索性结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号